Sumatriptan Nasal Spray for Acute Migraine
The efficacy and side effects of intranasal sumatriptan (20 mg, 10 mg) or placebo in the treatment of a single migraine attack were evaluated in two randomized, double-blind, multicenter studies of 409 and 436 adult patients, funded by Glaxo Wellcome.
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Pediatric Neurology Briefs Publishers
1997-12-01
|
| Col·lecció: | Pediatric Neurology Briefs |
| Matèries: | |
| Accés en línia: | https://www.pediatricneurologybriefs.com/articles/2284 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|